Van ECK Associates Corp Increases Stock Holdings in Stericycle, Inc. (NASDAQ:SRCL)

Van ECK Associates Corp grew its stake in shares of Stericycle, Inc. (NASDAQ:SRCLFree Report) by 19.7% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 89,398 shares of the business services provider’s stock after purchasing an additional 14,710 shares during the quarter. Van ECK Associates Corp’s holdings in Stericycle were worth $3,997,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Ancora Advisors LLC acquired a new stake in Stericycle during the first quarter worth approximately $34,000. Quarry LP acquired a new stake in Stericycle during the first quarter worth approximately $30,000. First Capital Advisors Group LLC. acquired a new stake in Stericycle during the second quarter worth approximately $36,000. International Assets Investment Management LLC acquired a new stake in Stericycle during the third quarter worth approximately $36,000. Finally, Point72 Middle East FZE acquired a new stake in Stericycle during the fourth quarter worth approximately $39,000. Institutional investors and hedge funds own 98.82% of the company’s stock.

Stericycle Stock Up 0.9 %

Shares of SRCL opened at $49.16 on Tuesday. The company’s 50 day simple moving average is $48.91 and its 200-day simple moving average is $45.53. Stericycle, Inc. has a 12-month low of $37.78 and a 12-month high of $55.96. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.90 and a current ratio of 0.90.

Analyst Upgrades and Downgrades

SRCL has been the topic of a number of research analyst reports. Wells Fargo & Company assumed coverage on shares of Stericycle in a report on Friday, December 8th. They set an “underweight” rating and a $40.00 price objective on the stock. Royal Bank of Canada lowered their target price on shares of Stericycle from $62.00 to $58.00 and set an “outperform” rating on the stock in a research report on Friday, November 3rd. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company’s stock. According to, the company currently has an average rating of “Hold” and an average price target of $53.20.

Check Out Our Latest Stock Analysis on SRCL

Stericycle Company Profile

(Free Report)

Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, controlled substance waste disposal, healthcare hazardous waste, and COVID 19 waste disposal; specialty services, such as MedDrop medication collection kiosks, safe community solutions, sharps mailback solutions, and maritime waste services; medical supply store services; pharmaceutical waste services; hazardous waste disposal; compliance programs under the Steri-Safe, Clinical Services, First Practice Management, SeguriMed, and EnviroAssure brand names.

Further Reading

Want to see what other hedge funds are holding SRCL? Visit to get the latest 13F filings and insider trades for Stericycle, Inc. (NASDAQ:SRCLFree Report).

Institutional Ownership by Quarter for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with's FREE daily email newsletter.